CHARLES SCHWAB INVESTMENT MANAGEMENT INC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$5,138,400
+1.8%
563,421
+18.0%
0.00%0.0%
Q2 2023$5,049,622
-12.3%
477,280
+1.3%
0.00%
-50.0%
Q1 2023$5,760,220
-1.0%
470,991
+0.4%
0.00%0.0%
Q4 2022$5,820,687
-5.6%
469,032
+3.9%
0.00%0.0%
Q3 2022$6,166,000
-28.4%
451,353
-3.9%
0.00%
-33.3%
Q2 2022$8,608,000
+12.0%
469,589
-1.7%
0.00%
+50.0%
Q1 2022$7,685,000
+17.9%
477,917
+2.6%
0.00%0.0%
Q4 2021$6,520,000
-23.4%
465,680
+2.5%
0.00%
-33.3%
Q3 2021$8,513,000
-9.4%
454,490
+0.8%
0.00%0.0%
Q2 2021$9,397,000
-25.0%
450,671
+1.7%
0.00%
-40.0%
Q1 2021$12,531,000
-9.0%
443,227
+5.1%
0.01%0.0%
Q4 2020$13,771,000
+24.8%
421,639
+17.1%
0.01%0.0%
Q3 2020$11,031,000
+105.5%
360,018
+9.3%
0.01%
+66.7%
Q2 2020$5,369,000
+113.6%
329,329
+30.3%
0.00%
+200.0%
Q1 2020$2,514,000
-27.1%
252,661
+0.8%
0.00%
-50.0%
Q4 2019$3,447,000
-6.9%
250,668
+2.7%
0.00%0.0%
Q3 2019$3,702,000
-18.4%
244,028
+5.9%
0.00%
-33.3%
Q2 2019$4,537,000
+22.1%
230,411
+2.8%
0.00%
+50.0%
Q1 2019$3,717,000
+62.8%
224,031
+37.8%
0.00%0.0%
Q4 2018$2,283,000
-20.8%
162,580
-1.3%
0.00%0.0%
Q3 2018$2,883,000
+177.2%
164,724
+188.3%
0.00%
+100.0%
Q2 2018$1,040,000
+22.6%
57,135
+26.5%
0.00%0.0%
Q1 2018$848,000
+35.2%
45,174
+10.3%
0.00%
Q4 2017$627,000
+6.8%
40,974
+4.5%
0.00%
-100.0%
Q3 2017$587,000
+159.7%
39,200
+61.3%
0.00%
Q2 2017$226,00024,3000.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders